SCYNEXIS, Inc. Share Price
SCYXSCYNEXIS, Inc. Stock Performance
Open $0.97 | Prev. Close $1.00 | Circuit Range N/A |
Day Range $0.96 - $0.99 | Year Range $0.57 - $1.30 | Volume 2,500 |
Average Traded $0.98 |
SCYNEXIS, Inc. Share Price Chart
About SCYNEXIS, Inc.
SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, a drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, CJSC (R-Pharm), and Cypralis Limited for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
SCYNEXIS, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $0.93 | $1.00 | +4.28% |
07-Apr-26 | $0.95 | $0.96 | +4.48% |
06-Apr-26 | $0.89 | $0.92 | +2.58% |
02-Apr-26 | $0.86 | $0.89 | +0.00% |
01-Apr-26 | $0.89 | $0.89 | -1.87% |
31-Mar-26 | $0.80 | $0.91 | +13.61% |
30-Mar-26 | $0.81 | $0.80 | -2.67% |
FAQs on SCYNEXIS, Inc. Share Price
Can I buy SCYNEXIS, Inc. shares in India?
What is the share price of SCYNEXIS, Inc.?
What is the 5 year returns of SCYNEXIS, Inc.?
What are the high & low stock price of SCYNEXIS, Inc. today?
What is the 52-week high and low of SCYNEXIS, Inc. stock?